Literature DB >> 31776552

A case of Takayasu arteritis complicated by refractory ulcerative colitis successfully treated with tofacitinib.

Shuzo Sato1, Haruki Matsumoto1, Jumpei Temmoku1, Yuya Fujita1, Naoki Matsuoka1, Makiko Furuya1, Naohiko Gunji2, Tatsuo Fujiwara2, Tomoyuki Asano1, Michio Onizawa2, Hiroko Kobayashi1, Hiroshi Watanabe1, Hiromasa Ohira2, Kiyoshi Migita1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31776552     DOI： 10.1093/rheumatology/kez580

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  9 in total

Review 1.  Characteristics of inflammatory bowel diseases in patients with concurrent immune-mediated inflammatory diseases.

Authors:  Shintaro Akiyama; Soma Fukuda; Joshua M Steinberg; Hideo Suzuki; Kiichiro Tsuchiya
Journal:  World J Gastroenterol       Date:  2022-07-07       Impact factor: 5.374

Review 2.  An Update on Childhood-Onset Takayasu Arteritis.

Authors:  Florence A Aeschlimann; Rae S M Yeung; Ronald M Laxer
Journal:  Front Pediatr       Date:  2022-04-13       Impact factor: 3.569

3.  Tofacitinib in patients with refractory Takayasu's arteritis.

Authors:  Jing Li; Mengtao Li; Xinping Tian; Xiaofeng Zeng
Journal:  Rheumatology (Oxford)       Date:  2020-11-01       Impact factor: 7.580

Review 4.  Cellular Signaling Pathways in Medium and Large Vessel Vasculitis.

Authors:  Ryu Watanabe; Gerald J Berry; David H Liang; Jörg J Goronzy; Cornelia M Weyand
Journal:  Front Immunol       Date:  2020-09-25       Impact factor: 7.561

Review 5.  Contribution of Janus-Kinase/Signal Transduction Activator of Transcription Pathway in the Pathogenesis of Vasculitis: A Possible Treatment Target in the Upcoming Future.

Authors:  Roberto Bursi; Giacomo Cafaro; Carlo Perricone; Ilenia Riccucci; Santina Calvacchi; Roberto Gerli; Elena Bartoloni
Journal:  Front Pharmacol       Date:  2021-03-29       Impact factor: 5.810

Review 6.  Novel Therapies in Takayasu Arteritis.

Authors:  Francesca Regola; Martina Uzzo; Paola Toniati; Barbara Trezzi; Renato Alberto Sinico; Franco Franceschini
Journal:  Front Med (Lausanne)       Date:  2022-01-12

Review 7.  Perspectives of JAK Inhibitors for Large Vessel Vasculitis.

Authors:  Ryu Watanabe; Motomu Hashimoto
Journal:  Front Immunol       Date:  2022-03-30       Impact factor: 7.561

Review 8.  Treatment of Giant Cell Arteritis and Takayasu Arteritis-Current and Future.

Authors:  B Hellmich; A F Águeda; S Monti; R Luqmani
Journal:  Curr Rheumatol Rep       Date:  2020-10-12       Impact factor: 4.592

9.  Coexistence of Takayasu's Arteritis in Patients with Inflammatory Bowel Diseases.

Authors:  Camilla de Almeida Martins; Ana Elisa Rabe Caon; Carolina Bortolozzo Graciolli Facanali; Carlos Walter Sobrado; Sergio Carlos Nahas; Rosa Maria Rodrigues Pereira; Reuma Margalit-Yehuda; Uri Kopylov; Natalia Sousa Freitas Queiroz
Journal:  Gastroenterol Res Pract       Date:  2021-02-12       Impact factor: 2.260
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.